Sugammadex Sodium Thio Acrylate - Request Quote
Sugammadex Sodium Thio Acrylate
| SZ CAT No: | SZ-S029051 |
| CAS No | NA |
| Mol.F. | C72H102O48S8 : 8(Na) |
| Mol.Wt. | 1992.0 : 8(23.0) |
| Inv. Status | In Stock |
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Sugammadex Sodium Thio Acrylate is chemically . Sugammadex Sodium Thio Acrylate is supplied with detailed characterization data compliant with regulatory guideline. Sugammadex Sodium Thio Acrylate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sugammadex.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Sugammadex Sodium Thio Acrylate
Purchase Sugammadex Sodium Thio Acrylate
Sugammadex Sodium Thio Acrylate suppliers
Sugammadex Sodium Thio Acrylate manufacturers
Sugammadex Sodium Thio Acrylate price
Order Sugammadex Sodium Thio Acrylate
Enquire Sugammadex Sodium Thio Acrylate
Sugammadex Sodium Thio Acrylate cost
Sugammadex Sodium Thio Acrylate Supplier
Sugammadex Sodium Thio Acrylate Distributor
Sugammadex Sodium Thio Acrylate for Method Validation
Sugammadex Reference Standard
Sugammadex Sodium Thio Acrylate for ANDA Filing
Sugammadex Sodium Thio Acrylate for Forced Degradation Studies
Sugammadex Sodium Thio Acrylate Identification Standards
Sugammadex Sodium Thio Acrylate for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


